Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus.
Connecting hydroxychloroquine in vitro antiviral activity to in vivo concentration for prediction of antiviral effect: a critical step in treating COVID-19 patients
- Jianghong Fan, Xinyuan Zhang, Yaning Wang
- Medicine, BiologyClinical infectious diseases : an official…
- 21 May 2020
In vitro EC50/EC90 values for hydroxy chloroquine should be compared to the in vivo free extracellular tissue concentration, which is similar to the free plasma hydroxychloroquine concentration.
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.
An Analysis of N-Acetylcysteine Treatment for Acetaminophen Overdose Using a Systems Model of Drug-Induced Liver Injury
- J. Woodhead, B. Howell, P. Watkins
- Medicine, BiologyJournal of Pharmacology and Experimental…
- 1 August 2012
DILIsym predicts that the oral NAC treatment protocol is superior to the 21-h intravenous protocol and ALT is the optimal available biomarker for discontinuation of the therapy.
Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration's Office of Clinical Pharmacology.
Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018‐2019 Submissions to the US FDA's Office of Clinical…
- Xinyuan Zhang, Yuching Yang, Yaning Wang
- Medicine, BiologyJournal of clinical pharmacology
- 1 October 2020
An update on the application of PBPK modeling in submissions received between 2018 and 2019 is provided and a few notable examples are highlighted.
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of…
FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis
The FDA clinical review and rationale for the approval of midostaurin for the treatment of adult patients with aggressive systemic mastocytosis, systemic mastocytes with associated hematological neoplasm, and mast cell leukemia is summarized.
In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym™: a mechanistic, mathematical model of DILI
- B. Howell, Yuching Yang, P. Watkins
- Biology, MedicineJournal of Pharmacokinetics and Pharmacodynamics
- 9 August 2012
This study demonstrates that mechanistic, mathematical modeling offers a method for interpreting and extrapolating results of drug-induced liver injury and illustrated how modeling can aid in selecting the most appropriate pre-clinical species for safety testing results relevant to humans.
Cross-species transcriptomic analysis of mouse and rat lung exposed to chloroprene.
- Russell S. Thomas, M. Himmelstein, M. Andersen
- Biology, MedicineToxicological sciences : an official journal of…
- 1 February 2013
Transcriptional BMD values for the pathway were more similar to differences in tumor response than were estimated target tissue dose surrogates based on the total amount of chloroprene metabolized per unit mass of lung tissue per day.